CUE
Cue Biopharma Inc
Price:  
1.14 
USD
Volume:  
235,377.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CUE WACC - Weighted Average Cost of Capital

The WACC of Cue Biopharma Inc (CUE) is 8.1%.

The Cost of Equity of Cue Biopharma Inc (CUE) is 8.20%.
The Cost of Debt of Cue Biopharma Inc (CUE) is 7.00%.

Range Selected
Cost of equity 7.00% - 9.40% 8.20%
Tax rate 0.30% - 0.70% 0.50%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.0% - 9.2% 8.1%
WACC

CUE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 9.40%
Tax rate 0.30% 0.70%
Debt/Equity ratio 0.12 0.12
Cost of debt 7.00% 7.00%
After-tax WACC 7.0% 9.2%
Selected WACC 8.1%